Price
No data yet.
Social Signal Score
Analyst Ratings
14 analystsRevenue
$1.47T+1687.31%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Juan Martin Parma
- Sector
- Financial Services
- Industry
- Banks - Regional
- Employees
- 8,180
- Beta
- 0.50
- Country
- AR
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 0.62
Financials
Revenue
$1.47T+1687.3%Net Income
$204.08B+717.4%EBITDA
$328.99B+3875.8%Free Cash Flow
$575.25BEPS (diluted)
$3193.40+648.4%Shares Outstanding (diluted)
63.90M+9.2%Operating Expenses
$356.70BCash & Debt
$3.33TReturn of Capital
$62.76BDividend per Share
$0.51Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.82T | $337.27B | $5281.60 |
| 2024 | $6.46T | $325.50B | $5090.60 |
| 2023 | $9.69T | $1.27T | $22388.80 |
| 2022 | $5.37T | $276.45B | $846.10 |
| 2021 | $1.70T | $138.74B | $457.80 |
| 2020 | $587.93B | $76.90B | $1202.30 |
| 2019 | $387.42B | $42.57B | $638.10 |
| 2018 | $2.77T | $-32.04B | $-493.50 |
| 2017 | $1.59T | $167.26B | $2468.70 |
| 2016 | $338.79B | $103.21B | $1742.00 |
| 2015 | $207.40B | $64.91B | $1110.30 |
| 2014 | $85.90B | $25.79B | $435.80 |
| 2013 | $44.46B | $13.14B | $222.10 |
| 2012 | $26.57B | $6.56B | $110.30 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from BMA's reported EPS growth of 34.7% a year over 13 years. Historical EPS growth of 35% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.
- EPS in 5 years
- $19,585
- Implied price
- $489,619
- Return from $64.55
- 497.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $243,427 — today's price is already 100.0% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 17 | 21 | 25 | 29 | 33 |
|---|---|---|---|---|---|
| 20.0% | 410.2% | 432.2% | 451.1% | 467.7% | 482.6% |
| 25.0% | 431.4% | 454.4% | 474.1% | 491.4% | 506.8% |
| 30.0% | 452.7% | 476.6% | 497.0% | 515.0% | 531.1% |
| 35.0% | 474.0% | 498.7% | 520.0% | 538.7% | 555.4% |
| 40.0% | 495.2% | 520.9% | 542.9% | 562.3% | 579.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
123+76.19%Social Signal Score
Mentions (19)
- Newszacks.com·3d ago·Positive
BMA vs. NABZY: Which Stock Is the Better Value Option? Investors interested in stocks from the Banks - Foreign sector have probably already heard of Banco Macro (BMA) and National Australia Bank Ltd. (NABZY). But which of these two companies is the best option for those looking for undervalued stocks?
View source ↗ - Newszacks.com·3d ago·Positive
Should Value Investors Buy Macro Bank (BMA) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
View source ↗ - Newszacks.com·5d ago·Positive
5 Low P/B Stocks With Attractive Value and Strong Growth Potential BMA, CNC, ENS, ROCK and KMT stand out among low P/B stocks, with strong Value Scores and projected 3-5-year EPS growth of up to 32.4%.
View source ↗ - Newszacks.com·19d ago·Positive
BMA vs. NABZY: Which Stock Should Value Investors Buy Now? Investors interested in stocks from the Banks - Foreign sector have probably already heard of Banco Macro (BMA) and National Australia Bank Ltd. (NABZY). But which of these two stocks is more attractive to value investors?
View source ↗ - Newszacks.com·19d ago·Positive
Are Investors Undervaluing Macro Bank (BMA) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
View source ↗ - Newsseekingalpha.com·20d ago·Neutral
Banco Macro: Weaker Operating Momentum Makes Me More Cautious Banco Macro remains a quality Argentine banking play, but near-term risk-reward has deteriorated. Q2 2026 earnings beat expectations, with EPS of $1.92 versus $1.46 consensus and resilient net interest margins. BMA revised loan growth guidance sharply lower to 2-5% for 2026, citing subdued credit demand and rising delinquencies.
View source ↗ - Newszacks.com·21d ago·Negative
Wall Street Analysts Predict a 44.99% Upside in Banco Macro (BMA): Here's What You Should Know The consensus price target hints at a 45% upside potential for Banco Macro (BMA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
View source ↗ - Newszacks.com·35d ago·Positive
BMA or NABZY: Which Is the Better Value Stock Right Now? Investors with an interest in Banks - Foreign stocks have likely encountered both Banco Macro (BMA) and National Australia Bank Ltd. (NABZY). But which of these two companies is the best option for those looking for undervalued stocks?
View source ↗ - Newszacks.com·35d ago·Positive
Should Value Investors Buy Macro Bank (BMA) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
View source ↗ - Newszacks.com·40d ago·Positive
Best Income Stocks to Buy for August 27th BMA, PROV and HMN made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 27th, 2026.
View source ↗ - Newszacks.com·45d ago·Neutral
Down 20.5% in 4 Weeks, Here's Why Banco Macro (BMA) Looks Ripe for a Turnaround The heavy selling pressure might have exhausted for Banco Macro (BMA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
View source ↗ - Newsseekingalpha.com·46d ago·Positive
Banco Macro S.A. (BMA) Q2 2026 Earnings Call Transcript Banco Macro S.A. (BMA) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·46d ago·Neutral
Macro Bank Q2 Earnings Call Highlights Macro Bank NYSE: BMA reported second-quarter 2026 net income of ARS 206.8 billion, up 39% from the prior quarter and 4% from a year earlier, as gains from financial instruments and lower loan-loss provisions outweighed pressure from moderating loan yields and continued restructuring costs.
View source ↗ - Newsprnewswire.com·47d ago·Neutral
Banco Macro Announces Results for the Second Quarter of 2026 BUENOS AIRES, Argentina, Aug. 19, 2026 /PRNewswire/ -- Banco Macro S.A. (NYSE: BMA; BYMA: BMA) ("Banco Macro" or "BMA" or the "Bank") announced today its results for the second quarter ended June 30, 2026 ("2Q26").
View source ↗ - Newsgurufocus.com·48d ago·Positive
Banco Macro SA (BMA) Shares Fall 3.5% -- What GF Score of 67 Tells Investors On August 18, 2026, Banco Macro SA (BMA) shares fell 3.5% to $76.08, reflecting a challenging market environment for the company. This decline comes alongside a
View source ↗ - Newszacks.com·49d ago·Neutral
Implied Volatility Surging for Banco Macro Stock Options Investors need to pay close attention to BMA stock based on the movements in the options market lately.
View source ↗ - Newszacks.com·52d ago·Neutral
BMA vs. NABZY: Which Stock Is the Better Value Option? Investors looking for stocks in the Banks - Foreign sector might want to consider either Banco Macro (BMA) or National Australia Bank Ltd. (NABZY). But which of these two stocks offers value investors a better bang for their buck right now?
View source ↗ - Newszacks.com·53d ago·Positive
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
View source ↗ - Newszacks.com·53d ago·Positive
Are Investors Undervaluing Macro Bank (BMA) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
View source ↗
Earnings
Wed, Nov 25(in 7 weeks)
Consensus estimate $2.07 per share
Typical surprise -2.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 19$2.17 vs $1.59beat
- Wed, May 27$1.59 vs $1.42beat
- Mon, Apr 20$1.24 vs $1.38miss
- Wed, Feb 25$1.98 vs $1.38beat
- Wed, Aug 27$1.95 vs $1.99miss
- Wed, May 28$0.65 vs $1.66miss
Estimates and results for BMA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BMA officers and directors.
- Bought
- $102k
- Sold
- —
1 trade
0 trades
- Brito Marcosbought
27 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in BMA.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.